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ABSTRACT Infrared spectroscopy was used to monitor the conformational change of 29,39-O-(2,4,6-trinitrophenyl)adenosine
59-monophosphate (TNP-AMP) binding to the sarcoplasmic reticulum Ca21-ATPase. TNP-AMP binding was observed in
a competition experiment: TNP-AMP is initially bound to the ATPase but is then replaced by b,g-iminoadenosine 59-
triphosphate (AMPPNP) after AMPPNP release from P3-1-(2-nitrophenyl)ethyl AMPPNP (caged AMPPNP). The resulting
infrared difference spectra are compared to those of AMPPNP binding to the free ATPase, to obtain a difference spectrum that
reﬂects solely TNP-AMP binding to the Ca21-ATPase. TNP-AMP used as an ATP analog in the crystal structure of the
sarcoplasmic reticulum Ca21-ATPase was found to induce a conformational change upon binding to the ATPase. It binds with
a binding mode that is different from that of AMPPNP, ATP, and other tri- and diphosphate nucleotides: TNP-AMP binding
causes partially opposite and smaller conformational changes compared to ATP or AMPPNP. The conformation of the TNP-
AMP ATPase complex is more similar to that of the E1Ca2 state than to that of the E1ATPCa2 state. Regarding the use of
infrared spectroscopy as a technique for ligand binding studies, our results show that infrared spectroscopy is able to distinguish
different binding modes.
INTRODUCTION
Ca21 transport from the cytoplasm of muscle cells into the
sarcoplasmic reticulum (SR), necessary for muscle relaxa-
tion, is performed by the SR Ca21-ATPase (Hasselbach and
Makinose, 1961; Hasselbach, 1974; De Meis and Vianna,
1979) which couples ATP hydrolysis to active Ca21
transport. The ATPase undergoes conformational changes
upon ATP binding and the subsequent phosphorylation
when ATP’s g-phosphate is transferred to Asp351. Nucleo-
tide binding to the ATPase has been studied intensively by
using ﬂuorescent ATP analogs like trinitrophenyl (TNP)
adenosine phosphates (Moczydlowski and Fortes, 1981a),
reviewed in McIntosh (1998). TNP-nucleotides have been
used not only because of their high ﬂuorescence yield and
photolabeling properties, but also on account of their high
binding afﬁnity. TNP-ATP, -ADP, and -AMP bind with high
afﬁnity to the catalytic sites of the Na1/K1-ATPase
(Moczydlowski and Fortes, 1981a,b), gastric H1/K1-
ATPase (Faller, 1989, 1990), and the SR Ca21-ATPase
(Dupont et al., 1982; Dupont and Pougeois, 1983; Watanabe
and Inesi, 1982; Berman, 1986; McIntosh et al., 1996). TNP-
AMP was used as ATP analog in the crystal structure of the
E1Ca2 state of the SR Ca
21-ATPase (Toyoshima et al.,
2000). It binds to the catalytic nucleotide binding site of
the Ca21-ATPase (Nakamoto and Inesi, 1984; Suzuki et al.,
1990). However, there is evidence that the structure with
ATP is different from that with TNP-AMP, since 1), TNP-
AMP binding to the ATPase cannot provide strong resistance
against proteinase K and V8 whereas ATP and adenosine 59-
(b,g-methylene)triphosphate (AMPPCP) can (Danko et al.,
2001); and 2), ATP binding destroys the E1Ca2 crystals
(MacLennan and Green, 2000) in contrast to TNP-AMP
(Toyoshima et al., 2000).
Here we investigate the conformational change of TNP-
AMP binding to the Ca21-ATPase in solution by infrared
spectroscopy. Conformational changes of the polypeptide
backbone upon binding lead to changes in amide I absorption,
which is sensitive to secondary structure. The amide I signals
therefore provide a ﬁngerprint of the conformational change
and enable an estimate of the net change of secondary struc-
ture (Barth et al., 1996). In our experiments we trigger nucleo-
tide binding by photolytic release from caged nucleotides
to detect the small infrared absorbance changes with high
sensitivity (Barth et al., 1990). Unfortunately, a caged deri-
vative of TNP-AMP is not available. Therefore we investigate
TNP-AMPbinding in an exchange or competition experiment
where AMPPNP replaces TNP-AMP from the binding site.
AMPPNP is released from caged AMPPNP and this triggers
AMPPNP binding in the presence of TNP-AMP. AMPPNP is
an excellent model for ATP since it induces very similar con-
formational changes (Barth et al., 1996; Von Germar et al.,
2000; Liu and Barth, 2002) and binds to the same site as
ATP (Clore et al., 1982). We use AMPPNP because it is
a nonphosphorylating analog of ATP. This prolongs the ob-
servation time for the nucleotide ATPase complex compared
to ATP and therefore enables a better signal-to-noise ratio of
the nucleotide binding spectrum. From the comparison of
AMPPNP binding in the presence and absence of TNPAMP
we are able to construct a TNPAMP binding spectrum. The
results indicate that TNP-AMP induces a conformational
change upon binding. The nature of conformational change
caused by TNP-AMP binding is different from that caused by
ATP or AMPPNP binding. The conformation of the TNP-
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AMP ATPase complex is more similar to that of the E1Ca2
state than to that of the E1ATPCa2 state.
MATERIALS AND METHODS
Sample preparation
SR vesicles were prepared as described (De Meis and Hasselbach, 1971).
After 60-min dialysis of SR vesicles in 10 mM methylimidazole/HCl, pH
7.5, 0.2 mM CaCl2, and 10 mM KCl, infrared samples were prepared by
vacuum drying 15 mL of SR suspension and further additions on a CaF2
window with a trough of 5-mm depth and 8-mm diameter and resuspending
the SR ﬁlm with ;0.8 mL H2O. The sample was sealed with a second ﬂat
CaF2 window. The samples contained ;1.2 mM Ca
21-ATPase, 0.5 mg/ml
Ca21 ionophore (A23187), 150 mMmethylimidazole, 150 mMKCl, 10 mM
CaCl2, TNP-AMP, and caged AMPPNP at different concentrations, and
DTT at the same concentration as caged AMPPNP.
As a control that the infrared signals are caused by nucleotide binding to
the Ca21-ATPase, thapsigargin (TG) (Kijima et al., 1991; Sagara et al.,
1992) was used to selectively inhibit the Ca21-ATPase in control samples.
The control samples were made as described in the following: after 60-min
dialysis of SR vesicles in the same buffer but with only 20 mMCaCl2, 15 mL
of SR suspension was incubated ﬁrst with mL of 0.6 mM EGTA for 5 min
and then with 1 mL of 1.2 mM TG for 5 min at 208C. After that the samples
were prepared as described in the paragraph above. The concentrations are
the same with the exception of the following concentrations in the control
samples: 0.3 mM CaCl2, 0.6 mM EGTA, and 1.2 mM TG.
Fourier transform infrared (FTIR) measurements
Time-resolved Fourier transform infrared (FTIR) measurements were
performed at 18C with a modiﬁed Bruker (Ettlingen, Germany) IFS 66
spectrometer and recorded with OPUS 3.0 (OS/2 version) at a resolution of
4 cm1 as described previously (Barth et al., 1996). Photolytic release of
AMPPNP was triggered by a Xenon ﬂash tube (N-185C, Xenon, Woburn
MA), which produces a ﬂash energy (at the area of the sample) of;150mJ in
the near-ultraviolet spectral range. The concentration of released AMPPNP
was determined by the amplitude of the band at 1525 cm1. A reference spec-
trum was recorded before the photolysis ﬂash. A spectrum was obtained by
averaging time-resolved spectra recorded in the time interval between 3.25 s
and 165.4 s after the photolytic release of AMPPNP. From this spectrum the
reference spectrum was subtracted to generate the raw difference spectrum.
A normalization of spectra to an identical protein concentration is not
necessary to generate the difference spectra, because they are obtained
directly from the time-resolved absorbance changes of individual samples.
However, when difference spectra of different samples were averaged to
improve the signal-to-noise ratio, the difference spectra from different
samples were normalized to a identical protein concentration by normalizing
the respective absorbance spectra to an amide II absorbance of 0.26
(difference in absorbance between 1546 and 1492 cm1) as described (Barth
and Ma¨ntele, 1998). This prevents the possible predominance of individual
samples with high protein content in the averaged difference spectra. The
absorbance spectra were recorded before the photolysis ﬂash and AMPPNP
binding. The absorbance in the amide II region does not depend on the
presence of ATP analogs because the absorbance of ATP and ATP analogs
is negligible in this region. The amide II band was chosen because it is less
sensitive to errors in water subtraction.
In contrast to difference spectra, normalization is a prerequisite for the
generation of the double difference spectrum of TNP-AMP binding, where
two normalized difference spectra are subtracted (see below).
Photolysis spectrum
To distinguish ligand-binding signals from signals due to caged AMPPNP
photolysis, we prepared control samples where the nucleotide binding sites
had already been saturated with AMPPNP at the beginning of the
experiment. The composition of these samples was the same as that of
samples containing caged AMPPNP and no TNP-AMP, with the exception
of 5 mM of added AMPPNP. Photolysis of 10 mM caged AMPPNP in the
control samples did not lead to further AMPPNP binding and conforma-
tional changes. The spectrum therefore shows only signals caused by the
photolysis of caged AMPPNP and is named the photolysis spectrum. The
conditions of recording the photolysis spectrum are as close as possible to
the conditions which were used in our binding and exchange experiments.
Ten experiments were averaged for the photolysis spectrum. The photolysis
spectrum was interactively subtracted from the raw difference spectra to
obtain the AMPPNP binding spectrum and the TNP-AMP ! AMPPNP
exchange spectrum (see below). The criterion for the correct multiplication
factor for the photolysis spectrum in the subtraction was as described (Von
Germar et al., 2000). The subtraction factor was judged to be correct when
the 1525 cm1 region of the processed spectrum corresponded to that region
in the spectrum obtained with [15N]caged ATP. 15N labeling shifts the band
of photolysis at 1525 cm1 to 1499 cm1, which allows the identiﬁcation of
underlying protein bands at ;1525 cm1.
AMPPNP binding spectrum
The AMPPNP binding spectrum refers to samples where the released
AMPPNP binds to the empty binding site of the ATPase. It was obtained
with samples containing caged AMPPNP and no TNP-AMP. Saturation of
AMPPNP binding in these experiments was veriﬁed by a titration of the
AMPPNP binding-induced infrared signals using consecutive releases of
AMPPNP from caged AMPPNP. Release of;3 mMAMPPNP from 10 mM
caged AMPPNP in one ﬂash was sufﬁcient to saturate the signals. Spectra of
four experiments were averaged with the Bruker spectrometer software
OPUS 3.1 (Windows NT version) to obtain the AMPPNP binding spectrum
and its standard deviation spectrum (shown in Fig. 4 B).
Control spectrum of the control samples
The control spectrumwas obtained in the same way as the AMPPNP binding
spectrum, using two control samples and applying one ﬂash which released
;3 mM AMPPNP from caged AMPPNP. Photolysis spectrum was
subtracted.
TNP-AMP titration of the TNP-AMP ! AMPPNP
exchange spectra
At the beginning of an exchange experiment, TNP-AMP was bound to the
ATPase. After the photolysis ﬂash, ;3 mM AMPPNP were released from
10 mM caged AMPPNP, completed with TNP-AMP, and partially replaced
TNP-AMP at the binding sites. The resulting difference spectra are named
TNP-AMP ! AMPPNP exchange spectra or simply the exchange spectra.
Different concentrations of TNP-AMP were used to determine the TNP-
AMP concentration that saturates the binding sites.
AMPPNP titration of the TNP-AMP ! AMPPNP
exchange spectra
To identify the AMPPNP concentration that nearly completely replaces
5 mM TNP-AMP from the binding sites, we performed an AMPPNP titra-
tion of the exchange spectrum in eight consecutive kinetic FTIR experiments
on one sample with one ﬂash for each experiment. In these experiments,
5 mM TNP-AMP and 30 mM caged AMPPNP were present. In the
ﬁrst experiment, ;3.7 mM AMPPNP was released; in the second a total
of;7 mM AMPPNP was present; and so on (Fig. 3 C). Signals from two
samples were averaged for the AMPPNP titration of the exchange spectra.
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TNP-AMP binding spectrum
The exchange spectrum shows the difference in absorbance between the
E1AMPPNPCa2 state and the E1TNP-AMPCa2 state, i.e., absorbance of
E1AMPPNPCa2 minus absorbance of E1TNP-AMPCa2. The AMPPNP
binding spectrum, measured under the same conditions but without TNP-
AMP added, shows the difference in absorbance between the E1AMPPNP-
Ca2 state and the E1Ca2 state, i.e., absorbance of E1AMPPNPCa2 minus
absorbance of E1Ca2. By subtracting the exchange spectrum from the
AMPPNP binding spectrum as shown in Scheme 1, we obtained the
difference in absorbance between the E1TNP-AMPCa2 state and the E1Ca2
state, i.e., the TNP-AMP binding spectrum: absorbance of E1TNP-AMPCa2
minus absorbance of E1Ca2.
Conﬁdence level spectra
As described, the TNP-AMP binding spectrum was obtained by subtracting
two normalized difference spectra. To assess the conﬁdence level of a double
difference spectrum like this, AMPPNP binding spectra of four samples
were divided into two groups with two spectra in each group. The spectra in
each group were averaged. The conﬁdence level spectra were obtained by
subtracting the averaged spectra. Since three possibilities exist to group the
spectra, we obtained three conﬁdence level spectra. These spectra are a check
of the reproducibility of the experiments.
Estimation of [E1AMPPNPCa2] from the infrared
spectra
The amplitude difference between 1644 and 1627 cm1 in the difference
spectrum can be used to estimate the concentration of the AMPPNP-ATPase
complex E1AMPPNPCa2, [EA]. At the selected wavenumbers, the spectrum
is hardly affected by TNP-AMP binding or dissociation (see circled
positions in the TNP-AMP binding spectrum in Fig. 4 A, which are zero
at these wavenumbers) and therefore reﬂects the concentration of the
AMPPNP-ATPase complex. The AMPPNP-induced amplitude difference at
a given TNPAMP concentration divided by the maximum amplitude
difference at zero TNPAMP concentration gives the ratio between [EA] and
the total ATPase concentration [Et] (see Figs. 2 C and 3 C). This ratio
represents the fraction of ATPase that binds AMPPNP, whereas the
remaining fraction binds TNP-AMP. Because of the high (mM) concentra-
tion of TNP-AMP used here, there is no free ATPase in our samples.
RESULTS
Origin of infrared absorbance changes
Fig. 1 shows the AMPPNP binding spectrum and a control
spectrum in which the Ca21-ATPase was selectively in-
hibited by thapsigargin in the presence of EGTA (Kijima
et al., 1991; Sagara et al., 1992; Fortea et al., 2001). These
control samples do not show binding signals. Samples
without thapsigargin but with 0.6 mM EGTA showed the
AMPPNP binding spectrum with the amplitude reduced to
;50%. This demonstrates that the signals obtained after the
release of AMPPNP are induced by AMPPNP binding to the
Ca21-ATPase.
In a previous study (Barth et al., 1991), ﬂuorescein
isothiocyanate (FITC) was used to determine the origin of
binding signals. FITC labels Lys515 of the Ca21-ATPase
and blocks the nucleotide binding site. FITC-labeled samples
did not show binding signals either, which indicates that
infrared signals are induced by nucleotide binding to the
Ca21-ATPase. Also samples in the presence of 20 mM
EGTA alone, where the ATPase was in a Ca21-free state,
did not show signiﬁcant ATP-induced infrared absorbance
changes (Barth et al., 1991). From these control experiments,
we infer that our infrared signals were caused by nucleotide
binding to the Ca21-ATPase.
We also investigated whether caged AMPPNP binds to the
ATPase. For this we varied the concentrations of caged
AMPPNP and ATPase. In the range from 1 mM to 10 mM
caged AMPPNP, the binding-induced infrared spectra were
identical within experimental errors, but decreased to two-
thirds of their amplitude when 30 or 50 mM caged AMPPNP
were used. This shows that the conformational change upon
AMPPNP binding is unaffected by the concentration of
caged AMPPNP up to a concentration of 10 mM. We con-
clude that caged AMPPNP binds to the ATPase in our
samples only when its concentration is[10 mM. This will
not be a problem for samples used to study TNP-AMP !
AMPPNP exchange. In these samples 30 mM of caged
FIGURE 1 Comparison of the AMPPNP binding spectrum and the
control spectrum. The AMPPNP binding spectrum (black thin line) is the
same as in Fig. 2 B obtained upon release of 3 mM AMPPNP in SR samples
(no TNP-AMP, no TG); the control spectrum (black bold line) was obtained
upon release of 3 mM AMPPNP in the SR vesicles after incubation with
EGTA (0.6 mM) and TG (1.2 mM) as described in Materials and Methods.
Absorbance changes due to caged AMPPNP photolysis were subtracted.
SCHEME1 Calculation of the TNP-AMPbinding spectrum; AðATPase stateÞ is the infrared absorbance of that state
AMPNP binding spectrum:AðE1AMPPNPCa2Þ-AðE1Ca2Þ
minus TNP-AMP! AMPPNP exchange spectrum: AðE1AMPPNPCa2Þ-AðE1TNP-AMPCa2Þ
TNP-AMPbinding spectrum: AðE1AMPPNPCa2Þ-AðE1TNP-AMPCa2Þ
3264 Liu and Barth
Biophysical Journal 85(5) 3262–3270
AMPPNP was used but the presence of 5 mM TNP-AMP
and the high afﬁnity of TNP-AMP ensure that TNP-AMP
and not caged AMPPNP is bound to the ATPase initially.
Competition between TNP-AMP and AMPPNP
To perform an experiment where AMPPNP replaces TNP-
AMP at the binding site of the Ca21-ATPase, we ﬁrst es-
tablished which concentration of TNP-AMP was needed to
saturate the nucleotide binding sites. For this purpose, dif-
ferent concentrations of TNP-AMP were used while the con-
centration of caged AMPPNP was 10 mM (;3 mM released
AMPPNP).
Fig. 2 A shows an infrared difference spectrum upon
release of 3 mM AMPPNP from caged AMPPNP in the ab-
sence of TNP-AMP and the photolysis spectrum that was
used for subtraction. It is clear that the subtraction of the pho-
tolysis spectrum will not affect either the amplitude or the
band positions above 1550 cm1 of the AMPPNP binding
spectrum or the TNP-AMP ! AMPPNP exchange spectra.
Fig. 2 B shows the AMPPNP binding spectrum and TNP-
AMP ! AMPPNP exchange spectra obtained at different
TNP-AMP concentrations. The associated absorption
changes cause negative and positive bands in the difference
spectra, which are characteristic of the conformation of the
enzyme before and after AMPPNP binding, respectively.
The difference spectra reﬂect conformational changes of the
protein in the amide I (1700–1610 cm1) and amide II region
(1580–1500 cm1) of the spectrum. In addition, environ-
mental and structural changes of side chains and nucleotide
contribute to the signals in the whole spectral region. As
shown in Fig. 2 B, increasing the TNP-AMP concentration to
5 mM reduces the amide I signals considerably because
TNP-AMP bound to the nucleotide binding site inhibits
AMPPNP binding. The positions of the largest bands shift
from 1640 and 1627 cm1 in the AMPPNP binding spectrum
(no TNP-AMP present) to 1639 and 1626 cm1 in the
exchange spectrum, which indicates that AMPPNP replaces
TNP-AMP from its binding site (discussed in the subsection
called TNP-AMP Binding Spectrum). If AMPPNP bound to
empty binding sites, no shift in band position would be
expected. No further shift in band position is observed at 10
and 30 mM TNP-AMP. Therefore 5 mM TNP-AMP seem to
saturate the nucleotide binding sites under our conditions. At
higher TNP-AMP concentrations, the exchange signals
decrease further because less TNP-AMP was replaced by
AMPPNP from the binding site. This experiment conﬁrms
that TNP-AMP and AMPPNP compete for the same binding
site on the protein (Bishop et al., 1987; Suzuki et al., 1990),
or at least that there is sufﬁcient overlap between the binding
sites to ensure efﬁcient competition.
Fig. 2 C shows the dependence of the fraction of ATPase
bound with AMPPNP on the concentration of TNP-AMP
([EA]/[Et]; see subsection called Estimation of [E1AMP
PNPCa2] from the Infrared Spectra). The fraction obtained
with 2.5 mM TNP-AMP and 3 mM released AMPPNP
is reduced to ;50% at nearly equimolar concentrations,
which shows that the afﬁnities of the two nucleotides are
similar.
Having identiﬁed the TNP-AMP concentration that
saturates the binding site, we established the conditions for
a nearly 100% exchange of TNP-AMP by AMPPNP in
a titration experiment: with a ﬁxed concentration of 5 mM
TNP-AMP, we increased the concentration of released
AMPPNP with consecutive photolysis ﬂashes (see sub-
section called AMPPNP Titration of the TNP-AMP !
FIGURE 2 Binding of 3 mM AMPPNP to the Ca21-ATPase in the
presence of different TNP-AMP concentrations (18C, pH 7.5). (A) Effects of
subtraction of the photolysis spectrum: the raw difference spectrum of 3 mM
AMPPNP release in the absence of TNP-AMP without subtraction of the
photolysis spectrum and the photolysis spectrum used for subtraction,
multiplied by a factor of 0.37. (B) The AMPPNP binding spectrum and
TNP-AMP ! AMPPNP exchange spectra. The labels show the band
positions of the AMPPNP binding spectrum (no TNP-AMP). (C) De-
pendence of the fraction of ATPase with bound AMPPNP on the
concentration of TNP-AMP, showing the inhibition of AMPPNP binding
by TNP-AMP (see subsection called Estimation of [E1AMPPNPCa2] from
the Infrared Spectra). Four experiments were averaged for the AMPPNP
binding spectrum in the absence of TNP-AMP. Three and two experiments
were averaged for the exchange spectra in the presence of 5 and 30 mM
TNP-AMP, respectively.
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AMPPNP Exchange Spectrum). Fig. 3 A shows the spectrum
upon release of;10 mM AMPPNP in the presence of 5 mM
TNP-AMP and the photolysis spectrum that was subtracted
to obtain the respective exchange spectrum in Fig. 3 B (thin
line). The small bands at 1664 and 1653 cm1 in the
photolysis spectrum may affect the amplitude but not the
band positions of the TNP-AMP ! AMPPNP exchange
spectra in the subtraction of the photolysis spectrum from the
raw difference spectrum of the exchange experiment. As
shown in Fig. 3 B, the signal amplitude of the exchange
spectra increase with the increase of released AMPPNP
showing that AMPPNP replaces TNP-AMP from the
binding sites. In Fig. 3 C the fraction of ATPases that bind
AMPPNP ([EA] / [Et]) is plotted against the photolysis band
at 1525 cm1, which is proportional to the concentration of
released AMPPNP. The proportion of the AMPPNP-ATPase
complex increases until the photolysis band at 1525 cm1
has reached an amplitude of 0.0025 corresponding to ;10
mM released AMPPNP, and shows the plateau from 10 mM
of released AMPPNP onwards. Therefore 10 mM of released
AMPPNP nearly completely replaces 5 mM TNP-AMP from
the binding sites and give saturating TNP-AMP !
AMPPNP exchange signals.
TNP-AMP binding spectrum
According to Fig. 3 C, releasing 10 mM AMPPNP is sufﬁ-
cient to nearly completely substitute 5 mM TNP-AMP in the
binding sites of the ATPase. The respective TNP-AMP !
AMPPNP exchange spectrum shows similar band positions
and band amplitudes as the AMPPNP binding spectrum
shown in Fig. 4 A. This similarity implies that AMPPNP
binding causes similar conformational changes whether or
not TNP-AMP is initially bound to the ATPase. However
upon closer inspection there are band shifts and amplitude
differences between the exchange and the AMPPNP binding
spectrum. For example, the bands at 1640 and 1627 cm1 in
the AMPPNP binding spectrum shift to 1639 and 1626 cm1
in the exchange spectrum; the amplitude of bands at 1692,
1675, and 1653 cm1 in the exchange spectrum is larger than
that of bands at 1692, 1681, and 1652 cm1 in the AMPPNP
binding spectrum; and the band at 1607 cm1 is not present
in the AMPPNP binding spectrum but is clearly negative in
the exchange spectrum.
FIGURE 3 TNP-AMP! AMPPNP exchange spectra in the presence of
5 mM TNP-AMP (18C, pH 7.5). (A) Effects of subtraction of the photolysis
spectrum: the raw difference spectrum of 10 mM AMPPNP release in the
presence of 5 mM TNP-AMP without subtraction of photolysis spectrum
and the photolysis spectrum used for the subtraction multiplied by a factor of
1.64. (B) TNP-AMP ! AMPPNP exchange spectra of the titration with
AMPPNP. (C) Dependence of the fraction of ATPase with bound AMPPNP
on the concentration of released AMPPNP in the presence of 5 mM TNP-
AMP (see subsection called Estimation of [E1AMPPNPCa2] from the
Infrared Spectra). Two experiments were averaged for each spectrum or data
point.
FIGURE 4 (A) Comparison of the AMPPNP binding spectrum (gray line,
gray labels), the TNP-AMP ! AMPPNP exchange spectrum at 10 mM
released AMPPNP and 5 mM TNP-AMP (thin line, labels in a box) and the
TNP-AMP binding spectrum (bold line, bold labels). (B) The standard
deviation of AMPPNP binding spectrum (light gray line) and three
conﬁdence level spectra (for deﬁnitions of other lines, see subsections
called Conﬁdence Level Spectra, and TNP-AMP Binding Spectrum).
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The difference between the respective experiments is that
TNP-AMP dissociation from the binding site contributes
to the exchange spectrum but not to the AMPPNP binding
spectrum where AMPPNP binds to the empty site. The
spectral differences between the spectra indicate that TNP-
AMP dissociation from the binding site causes conforma-
tional changes in addition to those of AMPPNP binding.
By subtracting the exchange spectrum from the AMPPNP
binding spectrum, the TNP-AMP binding spectrum (bold
line in Fig. 4 A) is obtained (see subsection called TNP-AMP
Binding Spectrum; see also Scheme 1), which shows the
infrared absorbance changes associated with TNP-AMP
binding. This spectrum is very different from the AMPPNP
binding spectrum or the ATP binding spectrum (Barth et al.,
1996; Von Germar et al., 2000; Liu and Barth, 2002), with
smaller bands often of opposite sign and at slightly different
positions. This indicates that TNP-AMP binding induces
different and minor conformational changes compared to
AMPPNP binding.
The TNP-AMP binding spectrum was obtained in a less
direct way than the AMPPNP binding spectrum and the
exchange spectrum, since it is the subtraction between two
normalized difference spectra. Therefore we discuss below
the signiﬁcance of bands in the TNP-AMP binding spectrum
by assessing the variations of band amplitudes and band
positions between different samples. Fig. 4 B shows the
standard deviation of the AMPPNP binding spectrum and
the conﬁdence level spectra to the same scale as in Fig. 4 A.
Conﬁdence level spectra assess the signiﬁcance of bands in
a double difference spectrum. They were calculated from the
four AMPPNP binding spectra obtained with four samples
as described in the subsection called AMPPNP Binding
Spectrum. In these conﬁdence level spectra, small bands at
1663, 1652, 1640, and 1627 cm1 were observed. These
bands are caused by small deviations in band amplitude
between the individual experiments. Therefore the largest
bands in the conﬁdence level spectra are usually observed at
peak positions of the AMPPNP binding spectrum. Bands of
the TNP-AMP binding spectrum are generally larger than
those of the conﬁdence spectra in the same spectral region
and all bands labeled in bold in Fig. 4 A were also observed
in additional experiments in which the released AMPPNP
was not enough to saturate the amplitude of the exchange
spectrum (data not shown). Despite that, we are careful to
attribute the small bands above 1680 cm1 to a conforma-
tional change upon TNP-AMP binding inasmuch as it is
difﬁcult to prove this rigorously. However, it is evident that
the bands at 1635 and 1624 cm1 in the TNP-AMP binding
spectrum show real differences between the TNP-AMP !
AMPPNP exchange spectrum and the AMPPNP binding
spectrum. These bands cannot be explained by a different
band amplitude in the difference spectra used in the
subtraction. Instead their effect can be detected already
upon comparing the AMPPNP binding and the exchange
spectrum, where they lead to different band positions: peak
positions vary for the AMPPNP binding spectra of the four
individual experiments from 1626.9 to 1627.3 cm1 and
from 1639.9 to 1640.4 cm1 and for the exchange spectra of
two individual experiments from 1639.2 to 1639.3 cm1. At
1625.9 cm1 the latter show the same peak position for both
experiments. The two peak positions are therefore clearly
different in the AMPPNP binding spectrum and the
TNPAMP ! AMPPNP exchange spectrum. Also the 1654
cm1 band of the TNP-AMP binding spectrum is observed at
a position different from that in either the AMPPNP binding
spectrum or the exchange spectrum, and the band at 1673
cm1 leads to a clearly different shape in the AMPPNP
binding spectrum and the exchange spectrum. Subtraction of
the photolysis spectrum hardly affects peak positions since it
changes the peak position only in one case by 0.1 cm1.
Therefore the different band positions in the AMPPNP and
the exchange spectrum are a clear indication of spectral
differences.
DISCUSSION
We have chosen TNP-AMP for our infrared study because it
was the nucleotide for which binding could be observed in
the ATPase crystals. The structure of the ATPase with bound
Ca21 and TNP-AMP is not signiﬁcantly different from that
in the absence of TNP-AMP (Toyoshima et al., 2000; Lee
and East, 2001), whereas ATP binding to the ATPase causes
a conformational change that destroys the crystals. In
solution, we detect a conformational change upon binding
of TNP-AMP to the SR Ca21-ATPase which is smaller than
that induced by binding of ATP or AMPPNP. Therefore,
infrared spectroscopy has detected a difference in the
structures of E1Ca2 and E1TNP-AMPCa2 that was not
detected by x-ray crystallography (Toyoshima et al., 2000).
The bands in the amide I region of the TNP-AMP binding
spectrum indicate that several secondary structure elements
are involved in TNP-AMP binding to the ATPase. Structure
changes of b-sheets can induce the bands at 1635 and 1624
cm1, of a-helices at 1654 cm1, and of turns at 1673 cm1.
In line with this, several residues of the ATPase in different
secondary structures have been found to be involved in TNP-
AMP binding: Thr441 in an a-helix is close to the surface of
the nucleotide binding site and interacts with the TNP moiety
(Toyoshima et al., 2000; Abu-Abed et al., 2002). Lys515 in
a b-strand, and Phe487 and Arg560 in loops interact with the
adenine moiety (McIntosh, 2000; Toyoshima et al., 2000;
Abu-Abed et al., 2002).
In another line of studies, we propose that the conforma-
tional changes caused by nucleotide binding are character-
istic of the bound nucleotides and several functional groups
of ATP have been found to be important for the binding-
induced conformational change such as the g-phosphate
group (Liu and Barth, 2002), the 29- and 39-OH groups in the
ribose ring, and the 6-membered ring of adenine (Liu and
Barth, 2003). The most likely explanation for this is a direct
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interaction of these groups with the protein. The binding
mode for the ATP analogs investigated (ITP, 29-, and 39-
deoxyATP, ADP) seems, however, to be similar to that of
ATP, since the shape of the spectra in the amide I region is
similar: they all show bands of the same sign as ATP or
AMPPNP near 1627, 1640, and 1652 cm1, and so do most
of them near 1662 and 1691 cm1. Table 1 compares the
positions of bands and shoulders for these close ATP
derivatives (Liu and Barth, 2003) with those of TNP-AMP
(this work). It can be seen that the character of the
conformational change caused by TNP-AMP binding is
largely opposite to that induced by the other nucleotides:
positive bands in the spectra of close ATP derivatives (near
1680, 1652, and 1628 cm1) appear as negative bands at
similar positions in the TNP-AMP binding spectrum (at
1673, 1654, and 1624 cm1); a negative band (near 1640
cm1) is positive at similar position in the TNP-AMP
binding spectrum (at 1635 cm1). The opposite character of
the TNP-AMP binding-induced spectrum is particularly
striking in the region of the largest bands, below 1660 cm1,
where all TNP-AMP bands have a sign opposite to that of all
bands of the other nucleotides investigated. If the confor-
mational change upon binding is described by a one-
dimensional parameter, similar to a reaction coordinate, then
the ATPase complexes with TNP-AMP and ATP lie on
opposite ends of the scale with the nucleotide free state
E1Ca2 in between, but closer to the TNP-AMP complex.
We think that the particular binding mode observed for
TNP-AMP is most likely due to the bulky TNP group
attached to the ribose moiety. This is because removal
of single functional groups of ATP (29-OH, 39-OH, or
g-phosphate) leads mainly to a reduction in band ampli-
tude compared to the ATP binding spectrum but retains most
of the spectral shape (Liu and Barth, 2003). From this we in-
fer that binding of the nucleotide moiety of TNP-AMP on its
own to the ATPase would lead to a further reduction in band
amplitude since it lacks three functional groups that are
important for the conformational change of the Ca21-
ATPase: the 29-OH, the 39-OH, and the g-phosphate group;
and, in addition, lacks the b-phosphate, which is important
for afﬁnity (Lacapere et al., 1990). This will make the
nucleotide moiety of TNP-AMP a low afﬁnity ligand for
the Ca21-ATPase. Therefore we attribute the high afﬁnity of
TNP-AMP and its particular binding mode detected here to
the TNP moiety of TNP-AMP.
The extent of conformational change can be estimated by
calculating the index of the change of backbone structure and
interaction (COBSI, see Barth et al., 1996). This index is
sensitive to secondary structure changes, changes in hydro-
gen bonding to peptide groups, and subtle structural changes
within a given secondary structure. Only net changes are
revealed. The index of COBSI with ATP binding is 7.5 3
104, and the index of COBSI with AMPPNP and TNP-AMP
binding is 7.0 3 104 and 3.1 3 104, respectively. This
shows that the extent of conformational changes induced
by TNP-AMP binding is signiﬁcant, being one-third to one-
half that of ATP and AMPPNP.
In our previous article (Liu and Barth, 2003) we discussed
that infrared spectroscopy will detect indirectly the antici-
pated hinge movement between nucleotide binding domain
N and phosphorylation domain P (Danko et al., 2001). This
hinge domain is thought to close the cleft between N and P
domain. Since the conformational changes upon TNP-AMP
binding have an opposite character to those of ATP binding,
we propose as a working hypothesis that TNP-AMP binding
opens the cleft. In line with that assumption, the cleft is wide
open in the crystal structure of E1TNP-AMPCa2 (Toyoshima
et al., 2000).
The TNP-AMP binding spectrum is somewhat similar to
the ADP-binding spectrum of mitochondrial creatine kinase
induced by caged ADP photolysis with negative bands at
1651 and 1624 cm1 and a positive band at 1640 cm1
(Raimbault et al., 1996) which indicates a similar binding
mode.
From a methodological point of view, we demonstrate that
competition experiments can be performed in the infrared
spectral region, from which relative dissociation constants
can be obtained without the need to develop a binding assay,
TABLE 1 Position of bands and shoulders in the nucleotide binding spectra in the amide I region
Nucleotide ATP AMPPNP ADP 29-dATP 39-dATP ITP TNP-AMP
Band positions 1698()
1693(1) 1692(1) 1693(1) 1693(1) 1692(1) 1691(1)
1680(1) 1681(1) 1680(1, s) 1682(1) 1679(1)
1678(1, s)
1673(, s) 1671(, s) 1672(, s) 1673()
1664() 1663() 1663() 1665() 1664(, s) 1663()
1652(1) 1652(1) 1652(1) 1652(1) 1653(1) 1652(1) 1654()
1641() 1640() 1641() 1641() 1642() 1641() 1635(+)
1628(1) 1627(1) 1628(1) 1628(1) 1628(1) 1626(1) 1624()
1616(1, s) 1616(1, s) 1616(1, s)
1607(1)
Key: s, shoulder; 1, positive band or shoulder; and , negative band or shoulder. TNP-AMP bands with a sign opposite to ATP-binding binds are indicated
in bold.
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and conﬁrm that different binding modes of ligands can
be detected as shown before (White and Wharton, 1990;
Murray et al., 1994; Ryan and Baenziger, 1999; and reviewed
in Wharton, 2000). Applications like this will soon gain
importance in fundamental and applied research when mix-
ing devices become commercially available that makes these
experiments just as easy to perform in the infrared spectral
region as in the visible spectral range. The advantage of in-
frared spectroscopy as a marker-free technique that directly
observes protein and ligand can then fully be exploited.
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